Insider Cluster (5 insiders) ·Filed Mar 2, 2026

ABT

ABBOTT LABORATORIES
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $98K total
Actionable Insight • Neutral

No material insider selling signal; activity is routine and tied to equity vesting tax settlements. Monitor for any open-market purchases or larger-than-normal sales ahead of earnings.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ABT ▼ -24.04% at T+60d
NEUTRAL call ✗ call lost -24.04% · α vs SPY -33.37% · entry $114.11 → $86.67
Entry anchored
Feb 27, 03:59 PM ET
via exchange tick
T+1d
-0.47%
call -0.47% · α +0.44%
$113.57
settled 7mo ago
T+5d
-1.31%
call -1.31% · α -0.11%
$112.61
settled 7mo ago
T+20d
-10.73%
call -10.73% · α -2.80%
$101.86
settled 6mo ago
T+60d
-24.04%
call -24.04% · α -33.37%
$86.67
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

A cluster of insider transactions at Abbott Laboratories over the past week includes open-market sales by two executives totaling $98K and tax withholding share surrenders by five executives, including the CEO and CFO, totaling $5.6 million. The majority of the activity represents non-cash tax settlements related to equity vesting, not discretionary selling.

Key Financial Metrics

Direction
selling
Total Value
$98.0K
Insiders
5

Key Facts

  • CEO Ford Robert B sold 30,308 shares via tax withholding (non-cash) at $116.26 = $3.52M
  • CFO Boudreau Philip P surrendered 7,441 shares for taxes = $865K
  • EVP Earnhardt Lisa D surrendered 8,577 shares for taxes = $997K
  • VP McCoy John A. Jr. sold 585 shares in open market = $67.6K and surrendered 1,142 for taxes = $132.8K
  • EVP Cushman Elizabeth C. sold 263 shares in open market = $30.4K and surrendered 1,421 for taxes = $165.2K
  • Total open-market sales: $98K (0.00005% of $198.3B market cap)
  • Total tax-related share surrenders: $5.6M

Financial Impact

$98,011.84 in open-market sales and $5.6 million in non-cash tax withholding transactions

insider ownershipshare count

Risk Factors

  • Misinterpretation of tax withholding as negative insider sentiment
  • Potential perception of lack of confidence if context is not understood

Market Snapshot

Price
$113.57
Volume
100
Exchange
NYSE
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (7 trades, 7d window)cluster-ABT-1772585762939
22 reports for ABT
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +17.16%Jul 1, 2026
Filters
Rows
Reports for ABT — sortable, filterable
TypeNow
Oct 2, 2026
today
ANALYST-UPGRADE
BULLISH ★ 4/10
$98.00 awaiting T+5awaiting T+5—$96.69 (−1.34%)
Sep 14, 2026
18d ago
Court Ruling
NEUTRAL ★ 1/10
$103.09 $102.98▼ −0.11%▼ −1.77%$96.69 (−6.21%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 2/10
$109.72 $112.68▲ +2.70%▲ +3.10%$96.69 (−11.88%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$109.72 $112.68▲ +2.70%▲ +3.10%$96.69 (−11.88%)
Jul 31, 2026
9w ago
Institutional Cluster
MIXED ★ 4/10
$105.70 $107.81▲ +2.00%▼ −1.51%$96.69 (−8.52%)
Jul 31, 2026
9w ago
Court Ruling
NEUTRAL ★ 2/10
$105.70 $107.81▲ +2.00%▼ −1.51%$96.69 (−8.52%)
Jul 24, 2026
10w ago
Court Ruling
BULLISH ★ 5/10
$103.06 $105.61▲ +2.47%▲ +2.10%$96.69 (−6.18%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$98.83 $100.75▲ +1.94%▲ +3.61%$96.69 (−2.17%)
Jul 14, 2026
11w ago
Court Ruling
NEUTRAL ★ 3/10
$88.96 $101.66▲ +14.28%▲ +15.57%$96.69 (+8.69%)
Jul 7, 2026
12w ago
Court Ruling
NEUTRAL ★ 1/10
$95.84 $88.96▼ −7.18%▼ −7.73%$96.69 (+0.89%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 4, 2026